-
5 Comments
Boston Scientific Corporation is currently in a long term uptrend where the price is trading 11.9% above its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.5.
Boston Scientific Corporation's total revenue sank by 6.7% to $3B since the same quarter in the previous year.
Its net income has dropped by 94.7% to $210M since the same quarter in the previous year.
Finally, its free cash flow grew by 1.6% to $514M since the same quarter in the previous year.
Based on the above factors, Boston Scientific Corporation gets an overall score of 3/5.
TradeWithAlerts
Follow
3 years, 3 months ago
|
ISIN | US1011371077 |
---|---|
Exchange | NYSE |
Industry | Medical Devices |
Sector | Healthcare |
CurrencyCode | USD |
Dividend Yield | 0.0% |
---|---|
Market Cap | 74B |
Target Price | 53.37 |
Beta | 0.79 |
PE Ratio | 114.44 |
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for BSX using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024